191 related articles for article (PubMed ID: 23649325)
1. Vaginal films for drug delivery.
Machado RM; Palmeira-de-Oliveira A; Martinez-De-Oliveira J; Palmeira-de-Oliveira R
J Pharm Sci; 2013 Jul; 102(7):2069-81. PubMed ID: 23649325
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent.
Garg S; Vermani K; Garg A; Anderson RA; Rencher WB; Zaneveld LJ
Pharm Res; 2005 Apr; 22(4):584-95. PubMed ID: 15846466
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
[TBL] [Abstract][Full Text] [Related]
4. Recent advances on anti-HIV vaginal delivery systems development.
Antimisiaris SG; Mourtas S
Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
[TBL] [Abstract][Full Text] [Related]
5. New strategies for local treatment of vaginal infections.
Palmeira-de-Oliveira R; Palmeira-de-Oliveira A; Martinez-de-Oliveira J
Adv Drug Deliv Rev; 2015 Sep; 92():105-22. PubMed ID: 26144995
[TBL] [Abstract][Full Text] [Related]
6. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy.
Woodsong C; Holt JD
Adv Drug Deliv Rev; 2015 Sep; 92():146-54. PubMed ID: 25703190
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive vaginal drug delivery systems.
Acartürk F
Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):193-205. PubMed ID: 19925443
[TBL] [Abstract][Full Text] [Related]
8. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
Beksinska M; Greener R; Smit J; Maphumulo B; Mphili N; Kilbourne-Brook M; Coffey PS
AIDS Behav; 2018 Jan; 22(1):127-132. PubMed ID: 28993940
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive and thermogelling systems for vaginal drug delivery.
Caramella CM; Rossi S; Ferrari F; Bonferoni MC; Sandri G
Adv Drug Deliv Rev; 2015 Sep; 92():39-52. PubMed ID: 25683694
[TBL] [Abstract][Full Text] [Related]
11. Special issue on vaginal drug delivery.
de Oliveira RP; de Oliveira JM; Caramella C
Adv Drug Deliv Rev; 2015 Sep; 92():1. PubMed ID: 26452325
[No Abstract] [Full Text] [Related]
12. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
Joanis CL; Hart CW
AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
[TBL] [Abstract][Full Text] [Related]
13. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow.
Lai BE; Xie YQ; Lavine ML; Szeri AJ; Owen DH; Katz DF
J Pharm Sci; 2008 Feb; 97(2):1030-8. PubMed ID: 17724667
[TBL] [Abstract][Full Text] [Related]
14. Polymer-based nanocarriers for vaginal drug delivery.
das Neves J; Nunes R; Machado A; Sarmento B
Adv Drug Deliv Rev; 2015 Sep; 92():53-70. PubMed ID: 25550217
[TBL] [Abstract][Full Text] [Related]
15. Post-expansile hydrogel foam aerosol of PG-liposomes: a novel delivery system for vaginal drug delivery applications.
Li WZ; Zhao N; Zhou YQ; Yang LB; Xiao-Ning W; Bao-Hua H; Peng K; Chun-Feng Z
Eur J Pharm Sci; 2012 Aug; 47(1):162-9. PubMed ID: 22705561
[TBL] [Abstract][Full Text] [Related]
16. Vaginal semisolid products: Technological performance considering physiologic parameters.
Machado RM; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Palmeira-de-Oliveira R
Eur J Pharm Sci; 2017 Nov; 109():556-568. PubMed ID: 28887234
[TBL] [Abstract][Full Text] [Related]
17. FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration.
Perioli L; Ambrogi V; Pagano C; Scuota S; Rossi C
Int J Pharm; 2009 Jul; 377(1-2):120-7. PubMed ID: 19454304
[TBL] [Abstract][Full Text] [Related]
18. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
[TBL] [Abstract][Full Text] [Related]
19. Electrospun solid dispersions of Maraviroc for rapid intravaginal preexposure prophylaxis of HIV.
Ball C; Woodrow KA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4855-65. PubMed ID: 24913168
[TBL] [Abstract][Full Text] [Related]
20. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.
Geonnotti AR; Peters JJ; Katz DF
J Pharm Sci; 2005 Aug; 94(8):1705-12. PubMed ID: 15986472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
